Invention Grant
- Patent Title: Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates
-
Application No.: US17692024Application Date: 2022-03-10
-
Publication No.: US11596669B2Publication Date: 2023-03-07
- Inventor: Boris Schwartsburd , Shaji Joseph
- Applicant: 89Bio, Inc.
- Applicant Address: US CA San Francisco
- Assignee: 89Bio, Inc.
- Current Assignee: 89Bio, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Greenberg Traurig, LLP
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61K47/54 ; A61P3/10 ; C07K14/50 ; A61K47/60
Abstract:
The present disclosure relates to liquid pharmaceutical compositions comprising mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate and prefilled syringe or autoinjector comprising liquid pharmaceutical compositions comprising mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate.
Public/Granted literature
- US20220296678A1 LIQUID FORMULATIONS COMPRISING MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES Public/Granted day:2022-09-22
Information query
IPC分类:
